RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
12.63
+0.14 (1.12%)
Dec 5, 2025, 4:00 PM EST - Market closed
RxSight Market Cap
RxSight has a market cap or net worth of $519.30 million as of December 5, 2025. Its market cap has decreased by -71.44% in one year.
Market Cap
519.30M
Enterprise Value
303.35M
1-Year Change
-71.44%
Ranking
Category
Stock Price
$12.63
Market Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has increased from $424.33M to $519.30M, an increase of 22.38%. That is a compound annual growth rate of 4.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 519.30M | -62.52% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |